Peter J. Neumann

Also affiliated with Tufts Medical Center

Economics, Econometrics and FinanceHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Racial and Ethnic Differences in Knowledge About One's Dementia Status”.

Racial and Ethnic Differences in Knowledge About One's Dementia Status

Journal of the American Geriatrics Society(2020)10.1111/jgs.16442

N/A

0DataRank · unranked

47 citations

Joanna Emerson, Jessica D. Faul, Joshua T. Cohen, Peter J. Neumann, Howard Fillit +4 more

The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease–2019 Treatments Available and Affordable

Value in Health(2020)10.1016/j.jval.2020.04.1824

N/A

0DataRank · unranked

21 citations

Joshua Cohen, Peter J. Neumann, Stefano Bertozzi, Anthony Kinghorn, Steven Forsythe

Preparing the health‐care system to pay for new Alzheimer's drugs

Alzheimer s & Dementia(2020)10.1002/alz.12155

N/A

0DataRank · unranked

14 citations

Joshua T. Cohen, Peter J. Neumann, Pei‐Jung Lin

Valuing Alzheimer Disease Therapies—Considering Costs and Benefits Beyond the Patient

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.31913

N/A

0DataRank · unranked

9 citations

Peter J. Neumann, Pei‐Jung Lin

Racial and Ethnic Differences in Hospice Use and Hospitalizations at End-of-Life Among Medicare Beneficiaries With Dementia

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.16260

N/A

0DataRank · unranked

69 citations

Yingying Zhu, Natalia Olchanski, Joshua T. Cohen, Peter J. Neumann, Jessica D. Faul +3 more

Alzheimer's disease medication use and adherence patterns by race and ethnicity

Alzheimer s & Dementia(2022)10.1002/alz.12753

N/A

0DataRank · unranked

21 citations

Allan T. Daly, Yingying Zhu, Rachel Milstein Breslau, Joshua T. Cohen, Peter J. Neumann +5 more

Addressing Challenges to Alternative Payment Models for New Alzheimer’s Disease Therapies for US Commercial Payers

PharmacoEconomics(2022)10.1007/s40273-022-01150-w

N/A

0DataRank · unranked

4 citations

Tara A. Lavelle, Peter J. Neumann, Pei‐Jung Lin, Jakub Hlávka

Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life

Journal of Alzheimer s Disease(2023)10.3233/jad-230692

N/A

0DataRank · unranked

15 citations

Natalia Olchanski, Joshua T. Cohen, Karen M. Freund, Jessica D. Faul, Howard Fillit +3 more

Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.29006

N/A

0DataRank · unranked

9 citations

Katherine A. Clifford, Daniel E. Enright, Peter J. Neumann, James D. Chambers

Attitudes on Equal Health Care Access versus Efficient Clinical Decisions across a Not-for-Profit Health Care System

Medical Decision Making(2023)10.1177/0272989x231206750

N/A

0DataRank · unranked

0 citations

Laura Corlin, Paul Beninger, Peter J. Neumann, Marcia M. Boumil, Shreya Mehta +2 more

Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study

Value in Health(2025)10.1016/j.jval.2025.01.008

N/A

0DataRank · unranked

0 citations

Natalia Olchanski, Karen M. Freund, Joshua T. Cohen, Peter J. Neumann, Pei‐Jung Lin +1 more